"My sister wants to kill me": A case report and systematic review of literature of co-occurring multiple sclerosis and psychosis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39100118/
This case highlights the importance of conducting a magnetic resonance imaging (MRI) brain not only for initial onset psychosis but also for any sudden changes in patients who have had...
A case report and literature review reveal co-occurring psychosis in multiple sclerosis patients, emphasizing the need for MRI evaluations and prompt management to enhance treatment adherence and patient outcomes.
Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38626023/
This study indicates that MRI can be used to predict the cognitive decline, disability progression, and disease progression in MS patients over time.
This study demonstrates that MRI effectively predicts cognitive decline, disability progression, and disease progression in Multiple Sclerosis patients by evaluating lesions and structural changes in the central nervous system.
Consensus quality indicators for monitoring multiple sclerosis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38585674/
Multiple sclerosis (MS) as a chronic, degenerative autoimmune disease of the central nervous system has a longitudinal and heterogeneous course with increasing treatment options and risk profiles requiring constant monitoring...
This study developed 24 measurable quality indicators (QIs) for monitoring multiple sclerosis care through literature review and expert consensus, aiming to enhance patient management and treatment outcomes.
Metabolomics in systemic sclerosis
Source : https://pubmed.ncbi.nlm.nih.gov/38981905/
Systemic sclerosis is a rare autoimmune condition leading to incurable complications. Therefore fast and precise diagnosis is crucial to prevent patient death and to maintain quality of life. Unfortunately, currently...
Metabolomic studies reveal significant differences between systemic sclerosis patients and controls; however, inconsistencies and inadequate patient descriptions necessitate further research for reliable biomarker identification and enhanced diagnostic accuracy.
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice
Source : https://pubmed.ncbi.nlm.nih.gov/39097537/
Cladribine tablets (CladT), like alemtuzumab, acts as an immune reconstitution therapy. However, CladT is administered orally (alemtuzumab is given by infusion) and without the potential for serious side effects that...
Cladribine tablets offer effective, well-tolerated immune reconstitution therapy for MS, providing long-term freedom from disease activity, with potential benefits for DMT-naïve patients and early intervention strategies.